Vertex to Acquire Crinetics Pharmaceuticals for $10.0 Billion, Expanding Rare Endocrine Disease Portfolio
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) and Crinetics Pharmaceuticals, Inc. announced a definitive agreement under which Vertex will acquire Crinetics for $85.00 per share in...
World’s First Once-Weekly Basal Insulin Now in India as Novo Nordisk Launches Awiqli®
In a major milestone for diabetes management, India has become one of the first countries globally to introduce Awiqli, the world’s first once-a-week basal insulin...
Rajasthan Recalls Labour-Inducing Gel Over Quality Test Failure
Rajasthan's Drug Control Department has ordered an immediate recall of a specific batch of Dinoprostone Gel, a critical drug commonly used to induce labour and soften...
skillzMap and PharmaGenDRx Sign Strategic MoU to Accelerate Skill Development in the Pharmaceutical and Life Sciences Sector
PharmaGenDRx, one of India's emerging platforms dedicated to pharmaceutical education, industry engagement, and career development, has signed a Memorandum of Understanding (MoU) with SkillzMap, a leading skill...
Maharashtra State Pharmacy Council Partners with IPC to Launch Dedicated “Pharmacovigilance & Medicine Safety” Web Portal
The Maharashtra State Pharmacy Council (MSPC), in a strategic collaboration with the Indian Pharmacopoeia Commission (IPC), announced the official launch of a dedicated “Pharmacovigilance...
FDA Grants Accelerated Approval to Vera Therapeutics’ TRUTAKNA™️ for Primary IgA Nephropathy
Vera Therapeutics, Inc. (Nasdaq: VERA) announced that the U.S. Food and Drug Administration (FDA) has granted accelerated approval to TRUTAKNA™ (atacicept-vymj). The therapy is...